APO Research

APO RESEARCH · REPORT

IVIg Liquid

Selected research

Market Outlook & Growth Opportunities

Global IVIg Liquid Market Outlook and Growth Opportunities 2026

Market perspective

The global IVIg Liquid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IVIg Liquid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the IVIg Liquid market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the IVIg Liquid market include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IVIg Liquid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IVIg Liquid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IVIg Liquid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IVIg Liquid market size, projected growth trends, production technologies, key applications, and end-use industries.

IVIg Liquid Segment by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

IVIg Liquid Segment by Type

50ml

25ml

IVIg Liquid Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

IVIg Liquid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global IVIg Liquid status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions IVIg Liquid market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify IVIg Liquid significant trends, drivers, influence factors in global and regions.

6. To analyze IVIg Liquid competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVIg Liquid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IVIg Liquid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVIg Liquid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IVIg Liquid market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IVIg Liquid industry.

Chapter 3: Detailed analysis of IVIg Liquid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of IVIg Liquid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of IVIg Liquid in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. IVIg Liquid Industry Trends Table 2. IVIg Liquid Industry Drivers Table 3. IVIg Liquid Industry Opportunities and Challenges Table 4. IVIg Liquid Industry Restraints Table 5. Global IVIg Liquid Revenue by Company (US$ Million) & (2021-2026) Table 6. Global IVIg Liquid Revenue Share by Company (2021-2026) Table 7. Global IVIg Liquid Sales Volume by Company (k units) & (2021-2026) Table 8. Global IVIg Liquid Sales Volume Share by Company (2021-2026) Table 9. Global IVIg Liquid Average Price (US$/unit) of Company (2021-2026) Table 10. Global IVIg Liquid Company Ranking, (2024-2026) & (USD Million) Table 11. Global IVIg Liquid Key Company Manufacturing Base & Headquarters Table 12. Global IVIg Liquid Company, Product Type & Application Table 13. Global IVIg Liquid Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global IVIg Liquid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50ml Table 18. Significant Companies of 25ml Table 19. Global IVIg Liquid Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global IVIg Liquid Sales Volume by Type (2021-2026) & (k units) Table 21. Global IVIg Liquid Sales Volume by Type (2027-2032) & (k units) Table 22. Global IVIg Liquid Sales Volume Share by Type (2021-2026) Table 23. Global IVIg Liquid Sales Volume Share by Type (2027-2032) Table 24. Global IVIg Liquid Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global IVIg Liquid Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global IVIg Liquid Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global IVIg Liquid Sales Value Share by Type (2021-2026) Table 28. Global IVIg Liquid Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Autoimmune Disease Table 30. Significant Companies of Immunodeficiency Table 31. Significant Companies of Acute Infection Table 32. Global IVIg Liquid Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global IVIg Liquid Sales Volume by Application (2021-2026) & (k units) Table 34. Global IVIg Liquid Sales Volume by Application (2027-2032) & (k units) Table 35. Global IVIg Liquid Sales Volume Share by Application (2021-2026) Table 36. Global IVIg Liquid Sales Volume Share by Application (2027-2032) Table 37. Global IVIg Liquid Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global IVIg Liquid Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global IVIg Liquid Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global IVIg Liquid Sales Value Share by Application (2021-2026) Table 41. Global IVIg Liquid Sales Value Share by Application (2027-2032) Table 42. Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global IVIg Liquid Sales by Region (2021-2026) & (k units) Table 44. Global IVIg Liquid Sales Market Share by Region (2021-2026) Table 45. Global IVIg Liquid Sales by Region (2027-2032) & (k units) Table 46. Global IVIg Liquid Sales Market Share by Region (2027-2032) Table 47. Global IVIg Liquid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global IVIg Liquid Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global IVIg Liquid Sales Value Share by Region (2021-2026) Table 50. Global IVIg Liquid Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global IVIg Liquid Sales Value Share by Region (2027-2032) Table 52. Global IVIg Liquid Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global IVIg Liquid Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global IVIg Liquid Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global IVIg Liquid Sales by Country (2021-2026) & (k units) Table 57. Global IVIg Liquid Sales Market Share by Country (2021-2026) Table 58. Global IVIg Liquid Sales by Country (2027-2032) & (k units) Table 59. Global IVIg Liquid Sales Market Share by Country (2027-2032) Table 60. Global IVIg Liquid Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global IVIg Liquid Sales Value Market Share by Country (2021-2026) Table 62. Global IVIg Liquid Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global IVIg Liquid Sales Value Market Share by Country (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Takeda IVIg Liquid Product Portfolio Table 68. Takeda Recent Development Table 69. Sichuan Yuanda Shuyang Company Information Table 70. Sichuan Yuanda Shuyang Business Overview Table 71. Sichuan Yuanda Shuyang IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio Table 73. Sichuan Yuanda Shuyang Recent Development Table 74. Shanghai RAAS Company Information Table 75. Shanghai RAAS Business Overview Table 76. Shanghai RAAS IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shanghai RAAS IVIg Liquid Product Portfolio Table 78. Shanghai RAAS Recent Development Table 79. Hualan Bio Company Information Table 80. Hualan Bio Business Overview Table 81. Hualan Bio IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Hualan Bio IVIg Liquid Product Portfolio Table 83. Hualan Bio Recent Development Table 84. Octapharma Company Information Table 85. Octapharma Business Overview Table 86. Octapharma IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Octapharma IVIg Liquid Product Portfolio Table 88. Octapharma Recent Development Table 89. LFB Group Company Information Table 90. LFB Group Business Overview Table 91. LFB Group IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. LFB Group IVIg Liquid Product Portfolio Table 93. LFB Group Recent Development Table 94. Kedrion Company Information Table 95. Kedrion Business Overview Table 96. Kedrion IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Kedrion IVIg Liquid Product Portfolio Table 98. Kedrion Recent Development Table 99. Grifols Company Information Table 100. Grifols Business Overview Table 101. Grifols IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Grifols IVIg Liquid Product Portfolio Table 103. Grifols Recent Development Table 104. CSL Company Information Table 105. CSL Business Overview Table 106. CSL IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. CSL IVIg Liquid Product Portfolio Table 108. CSL Recent Development Table 109. CNBG Company Information Table 110. CNBG Business Overview Table 111. CNBG IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. CNBG IVIg Liquid Product Portfolio Table 113. CNBG Recent Development Table 114. CBPO Company Information Table 115. CBPO Business Overview Table 116. CBPO IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. CBPO IVIg Liquid Product Portfolio Table 118. CBPO Recent Development Table 119. BPL Company Information Table 120. BPL Business Overview Table 121. BPL IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. BPL IVIg Liquid Product Portfolio Table 123. BPL Recent Development Table 124. Biotest Company Information Table 125. Biotest Business Overview Table 126. Biotest IVIg Liquid Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Biotest IVIg Liquid Product Portfolio Table 128. Biotest Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. IVIg Liquid Distributors List Table 132. IVIg Liquid Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. IVIg Liquid Product Image Figure 2. Global IVIg Liquid Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 4. Global IVIg Liquid Sales (2021-2032) & (k units) Figure 5. Global IVIg Liquid Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global IVIg Liquid Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50ml Image Figure 10. 25ml Image Figure 11. Global IVIg Liquid Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global IVIg Liquid Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global IVIg Liquid Sales Volume Share by Type (2021-2032) Figure 14. Global IVIg Liquid Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global IVIg Liquid Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global IVIg Liquid Sales Value Share by Type (2021-2032) Figure 17. Autoimmune Disease Image Figure 18. Immunodeficiency Image Figure 19. Acute Infection Image Figure 20. Global IVIg Liquid Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global IVIg Liquid Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global IVIg Liquid Sales Volume Share by Application (2021-2032) Figure 23. Global IVIg Liquid Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global IVIg Liquid Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global IVIg Liquid Sales Value Share by Application (2021-2032) Figure 26. Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global IVIg Liquid Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global IVIg Liquid Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global IVIg Liquid Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 31. North America IVIg Liquid Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 33. Europe IVIg Liquid Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific IVIg Liquid Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 37. South America IVIg Liquid Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa IVIg Liquid Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa IVIg Liquid Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt IVIg Liquid Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt IVIg Liquid Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt IVIg Liquid Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. IVIg Liquid Value Chain Figure 125. Manufacturing Cost Structure Figure 126. IVIg Liquid Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 25ml
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IVIg Liquid Sales Value (2021-2032)
  4. 1.2.2 Global IVIg Liquid Sales Volume (2021-2032)
  5. 1.2.3 Global IVIg Liquid Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 IVIg Liquid Market Dynamics
  1. 2.1 IVIg Liquid Industry Trends
  2. 2.2 IVIg Liquid Industry Drivers
  3. 2.3 IVIg Liquid Industry Opportunities and Challenges
  4. 2.4 IVIg Liquid Industry Restraints
3 IVIg Liquid Market by Company
  1. 3.1 Global IVIg Liquid Company Revenue Ranking in 2025
  2. 3.2 Global IVIg Liquid Revenue by Company (2021-2026)
  3. 3.3 Global IVIg Liquid Sales Volume by Company (2021-2026)
  4. 3.4 Global IVIg Liquid Average Price by Company (2021-2026)
  5. 3.5 Global IVIg Liquid Company Ranking (2024-2026)
  6. 3.6 Global IVIg Liquid Company Manufacturing Base and Headquarters
  7. 3.7 Global IVIg Liquid Company Product Type and Application
  8. 3.8 Global IVIg Liquid Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global IVIg Liquid Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 IVIg Liquid Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 IVIg Liquid Market by Type
  1. 4.1 IVIg Liquid Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 25ml
  4. 4.2 Global IVIg Liquid Sales Volume by Type
  5. 4.2.1 Global IVIg Liquid Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global IVIg Liquid Sales Volume by Type (2021-2032)
  7. 4.2.3 Global IVIg Liquid Sales Volume Share by Type (2021-2032)
  8. 4.3 Global IVIg Liquid Sales Value by Type
  9. 4.3.1 Global IVIg Liquid Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global IVIg Liquid Sales Value by Type (2021-2032)
  11. 4.3.3 Global IVIg Liquid Sales Value Share by Type (2021-2032)
5 IVIg Liquid Market by Application
  1. 5.1 IVIg Liquid Application Introduction
  2. 5.1.1 Autoimmune Disease
  3. 5.1.2 Immunodeficiency
  4. 5.1.3 Acute Infection
  5. 5.2 Global IVIg Liquid Sales Volume by Application
  6. 5.2.1 Global IVIg Liquid Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IVIg Liquid Sales Volume by Application (2021-2032)
  8. 5.2.3 Global IVIg Liquid Sales Volume Share by Application (2021-2032)
  9. 5.3 Global IVIg Liquid Sales Value by Application
  10. 5.3.1 Global IVIg Liquid Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global IVIg Liquid Sales Value by Application (2021-2032)
  12. 5.3.3 Global IVIg Liquid Sales Value Share by Application (2021-2032)
6 IVIg Liquid Regional Sales and Value Analysis
  1. 6.1 Global IVIg Liquid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IVIg Liquid Sales by Region (2021-2032)
  3. 6.2.1 Global IVIg Liquid Sales by Region: 2021-2026
  4. 6.2.2 Global IVIg Liquid Sales by Region (2027-2032)
  5. 6.3 Global IVIg Liquid Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global IVIg Liquid Sales Value by Region (2021-2032)
  7. 6.4.1 Global IVIg Liquid Sales Value by Region: 2021-2026
  8. 6.4.2 Global IVIg Liquid Sales Value by Region (2027-2032)
  9. 6.5 Global IVIg Liquid Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America IVIg Liquid Sales Value (2021-2032)
  12. 6.6.2 North America IVIg Liquid Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe IVIg Liquid Sales Value (2021-2032)
  15. 6.7.2 Europe IVIg Liquid Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific IVIg Liquid Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific IVIg Liquid Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America IVIg Liquid Sales Value (2021-2032)
  21. 6.9.2 South America IVIg Liquid Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa IVIg Liquid Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa IVIg Liquid Sales Value Share by Country, 2025 VS 2032
7 IVIg Liquid Country-level Sales and Value Analysis
  1. 7.1 Global IVIg Liquid Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global IVIg Liquid Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global IVIg Liquid Sales by Country (2021-2032)
  4. 7.3.1 Global IVIg Liquid Sales by Country (2021-2026)
  5. 7.3.2 Global IVIg Liquid Sales by Country (2027-2032)
  6. 7.4 Global IVIg Liquid Sales Value by Country (2021-2032)
  7. 7.4.1 Global IVIg Liquid Sales Value by Country (2021-2026)
  8. 7.4.2 Global IVIg Liquid Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA IVIg Liquid Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada IVIg Liquid Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico IVIg Liquid Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany IVIg Liquid Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France IVIg Liquid Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. IVIg Liquid Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy IVIg Liquid Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain IVIg Liquid Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia IVIg Liquid Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands IVIg Liquid Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries IVIg Liquid Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China IVIg Liquid Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan IVIg Liquid Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea IVIg Liquid Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India IVIg Liquid Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia IVIg Liquid Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia IVIg Liquid Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil IVIg Liquid Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina IVIg Liquid Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile IVIg Liquid Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia IVIg Liquid Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru IVIg Liquid Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia IVIg Liquid Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel IVIg Liquid Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE IVIg Liquid Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey IVIg Liquid Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran IVIg Liquid Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran IVIg Liquid Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt IVIg Liquid Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt IVIg Liquid Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt IVIg Liquid Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda IVIg Liquid Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sichuan Yuanda Shuyang
  8. 8.2.1 Sichuan Yuanda Shuyang Company Information
  9. 8.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 8.2.3 Sichuan Yuanda Shuyang IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Yuanda Shuyang IVIg Liquid Product Portfolio
  12. 8.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS IVIg Liquid Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio IVIg Liquid Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 Octapharma
  26. 8.5.1 Octapharma Company Information
  27. 8.5.2 Octapharma Business Overview
  28. 8.5.3 Octapharma IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Octapharma IVIg Liquid Product Portfolio
  30. 8.5.5 Octapharma Recent Developments
  31. 8.6 LFB Group
  32. 8.6.1 LFB Group Company Information
  33. 8.6.2 LFB Group Business Overview
  34. 8.6.3 LFB Group IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LFB Group IVIg Liquid Product Portfolio
  36. 8.6.5 LFB Group Recent Developments
  37. 8.7 Kedrion
  38. 8.7.1 Kedrion Company Information
  39. 8.7.2 Kedrion Business Overview
  40. 8.7.3 Kedrion IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Kedrion IVIg Liquid Product Portfolio
  42. 8.7.5 Kedrion Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Grifols IVIg Liquid Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 CSL
  50. 8.9.1 CSL Company Information
  51. 8.9.2 CSL Business Overview
  52. 8.9.3 CSL IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CSL IVIg Liquid Product Portfolio
  54. 8.9.5 CSL Recent Developments
  55. 8.10 CNBG
  56. 8.10.1 CNBG Company Information
  57. 8.10.2 CNBG Business Overview
  58. 8.10.3 CNBG IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CNBG IVIg Liquid Product Portfolio
  60. 8.10.5 CNBG Recent Developments
  61. 8.11 CBPO
  62. 8.11.1 CBPO Company Information
  63. 8.11.2 CBPO Business Overview
  64. 8.11.3 CBPO IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CBPO IVIg Liquid Product Portfolio
  66. 8.11.5 CBPO Recent Developments
  67. 8.12 BPL
  68. 8.12.1 BPL Company Information
  69. 8.12.2 BPL Business Overview
  70. 8.12.3 BPL IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BPL IVIg Liquid Product Portfolio
  72. 8.12.5 BPL Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest IVIg Liquid Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Biotest IVIg Liquid Product Portfolio
  78. 8.13.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IVIg Liquid Value Chain Analysis
  2. 9.1.1 IVIg Liquid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IVIg Liquid Sales Mode & Process
  6. 9.2 IVIg Liquid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IVIg Liquid Distributors
  9. 9.2.3 IVIg Liquid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research